TickerFacts.

Zivo Bioscience, Inc. (ZIVO): Shares Outstanding

Annual figures by period end, from SEC filings.

Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2019-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

3.62M
As of 2024-12-31
3.83M
As of 2025-09-30
413.04M2010-12-31: 92.71M2011-12-31: 100.04M2012-12-31: 105.32M2013-12-31: 116.85M2014-12-31: 128.77M2015-12-31: 132.16M2016-12-31: 136.75M2017-12-31: 141.11M2018-12-31: 180.04M2019-12-31: 413.04M2020-12-31: 5.16M2021-12-31: 9.42M2022-12-31: 1.57M2023-12-31: 2.38M2024-12-31: 3.62M3.62M
2010-12-31 Shares Outstanding (shares) 2024-12-31
Period endedShares OutstandingChange YoYSource filing
2024-12-313.62M+52.0%2025-03-18, Balance as of period end
2023-12-312.38Mn/c2025-03-18, Balance as of period end
2022-12-311.57M-83.3%2024-03-15, Balance as of period end
2021-12-319.42M+82.4%2023-03-14, Balance as of period end
2020-12-315.16M-98.8%2022-04-22, Balance as of period end
2019-12-31413.04Mn/c2021-02-25, Balance as of period end
2018-12-31180.04M+27.6%2020-03-26, Balance as of period end
2017-12-31141.11M+3.2%2019-02-12, Balance as of period end
2016-12-31136.75M+3.5%2018-02-21, Balance as of period end
2015-12-31132.16M+2.6%2017-03-31, Balance as of period end
2014-12-31128.77M+10.2%2016-03-29, Balance as of period end
2013-12-31116.85M+11.0%2015-04-06, Balance as of period end
2012-12-31105.32M+5.3%2014-03-31, Balance as of period end
2011-12-31100.04M+7.9%2013-03-25, Balance as of period end
2010-12-3192.71Mn/a2012-03-30, Balance as of period end